Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
- DOI
- 10.1093/humrep/dez007
- Published
- 2019 Apr 1
- Container
- Human reproduction (Oxford, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/humrep/dez007,
title = {Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.},
author = {Stewart EA and Diamond MP and Williams ARW and Carr BR and Myers ER and Feldman RA and Elger W and Mattia-Goldberg C and Schwefel BM and Chwalisz K},
year = {2019},
journal = {Human reproduction (Oxford, England)},
doi = {10.1093/humrep/dez007},
url = {https://doi.org/10.1093/humrep/dez007}
}RIS
TY - JOUR TI - Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials. AU - Stewart EA AU - Diamond MP AU - Williams ARW AU - Carr BR AU - Myers ER AU - Feldman RA AU - Elger W AU - Mattia-Goldberg C AU - Schwefel BM AU - Chwalisz K PY - 2019 JO - Human reproduction (Oxford, England) DO - 10.1093/humrep/dez007 UR - https://doi.org/10.1093/humrep/dez007 ER -
APA
EA, S., MP, D., ARW, W., BR, C., ER, M., RA, F., W, E., C, M., BM, S., & K, C. (2019). Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.. Human reproduction (Oxford, England). https://doi.org/10.1093/humrep/dez007
Source records
- pubmed · retrieved 2026-09-26T20:46:03.408Z